Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM
Original Article from The New England Journal of Medicine — Compassionate Use of Remdesivir for Patients with Severe Covid-19
Related Articles
Unilever to Cut 7,500 Jobs and Spin Off Ben & Jerry’s Ice Cream Unit
The consumer goods giant said the moves would make for a “simpler, more focused company” as consumers trade down to cheaper brands amid high inflation.
Nancy E. Adler, Who Linked Wealth to Health, Dies at 77
She documented the powerful role that education, income and self-perceived social status play in a person’s health and longevity.
How a “Netflix Model” Can Help States Pay for Hepatitis C Treatment – Drug Pricing Lab
Dr. Peter B, Bach, Director of Memorial Sloan Kettering’s Dug Pricing Lab, and co-authors Mark R. Trusheim of MIT and Dr, William Cassidy, former governor…
Vanderbilt’s Dr. W. Kimryn Rathmell to be appointed director of the National Cancer Institute
Kimryn Rathmell, MD, PhD, MMHC, the Hugh Jackson Professor of Medicine and chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), has…
Vanderbilt’s Dr. W. Kimryn Rathmell to be appointed director of the National Cancer Institute
Kimryn Rathmell, MD, PhD, MMHC, the Hugh Jackson Professor of Medicine and chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), has…
Forward Therapeutics Announces $50 Million Series A Financing – Forward Therapeutics
Announcing Series A financing led by BVF Partners, RA Capital and Orbimed.
Delfi launches its blood test to screen for lung cancer – and reveals challenges for liquid biopsies
Taking aim at a major killer, the well-funded startup Delfi Diagnostics launches a blood test to screen for lung cancer.
What a viral study criticizing cancer screening gets very, very wrong
A new study says that most cancer screening doesn’t save lives. But proving that kind of negative isn’t just hard — it’s impossible.
What a viral study criticizing cancer screening gets very, very wrong
A new study says that most cancer screening doesn’t save lives. But proving that kind of negative isn’t just hard — it’s impossible.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening | NEJM
Original Article from The New England Journal of Medicine — Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening